InvestorsHub Logo
icon url

Jhawker

01/03/21 11:12 AM

#338580 RE: olden_grumpini #338578

Not all drugs in covid trials have gone through the same preclinical testing B has and furthermore tiab has said that he works in a very small hospital which has not seen many covid patients.
icon url

williamssc

01/03/21 11:36 AM

#338583 RE: olden_grumpini #338578

"Extensive pre-clinical research, nearing completion, conducted at independent laboratories reinforces the antiviral potential of Brilacidin against SARS-CoV-2, the novel coronavirus responsible for COVID-19. Numerous hospitals and provider networks domestically and abroad have expressed a strong interest in participating in the Brilacidin for COVID-19 clinical trial. Given such interest in Brilacidin, the Company anticipates the planned COVID-19 trial can be rapidly recruited and completed."

There you have it providers wanting to participate.
icon url

roiresearch

01/03/21 11:46 AM

#338585 RE: olden_grumpini #338578

hypertension. the previous study i can find any hyperstension info on said 6 of 160 patients receiving B showed signs of hbp. 3 of these patients were in the high dose group. The 1 patient in the low dose group reporting having pre-existing hypertension. maybe i am looking at the wrong study. thanks